Pharmafile Logo
Pharmafocus logo
Advanced Search
humira_abbott__4

Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar

April 6, 2018
Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …

News
roche_close

Roche suffers Ocrevus knockback by NICE

April 6, 2018
Medical Communications, Sales and Marketing Ocrevus, Roche, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

Roche’s multiple sclerosis drug, Ocrevus (ocrelizumab), has been a big new growth driver for the company, especially in the US, …

News
shutterstock_274590824

J&J pays out $37m in damages over claims its talc contains asbestos

April 6, 2018
Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …

News
china_block_001_takeda

Takeda move for Shire looks increasingly likely

April 6, 2018
Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical

Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …

News
luigi_costa_credit_nordic_nanovector_headshot

Nordic Nanovector CEO steps down as company delays R&D timelines

April 5, 2018
Medical Communications, Research and Development, Sales and Marketing Luigi Costa, Nordic Nanovector, pharma

Norwegian biopharmaceutical firm Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from …

News
cystic_fibrosis_insider_interview

Transforming cystic fibrosis treatment

April 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …

Feature
roche

Roche snaps up Inception neuroscience program

April 5, 2018
Sales and Marketing Pipeline Therapeutics, Roche, biotech, drugs, pharma, pharmaceutical

Back in 2014, Roche entered into strategic collaboration with Inception Sciences to look into the regenerative medicines space for multiple …

News

Boehringer teams up with OSE in €1.1 billion cancer drug partnership

April 5, 2018
Sales and Marketing Boehringer, Cancer, OSE Immunotherapeutics, partnership, pharma

Boehringer Ingelheim and biotech firm OSE Immunotherapeutics have announced that they have entered an exclusive collaboration and license agreement to …

News
sugar

Obesity admissions double in four years

April 5, 2018
Medical Communications NHS, UK, biotech, drugs, pharma, pharmaceutical

New figures show that hospital admissions related to obesity have doubled over the last four years in the UK, placing …

News
lilly2_web

Lilly and Sigilon team up in $473m+ deal to ‘cure’ diabetes

April 5, 2018
Sales and Marketing Eli Lilly, Sigilon Therapeutics, biotech, drugs, pharma, pharmaceutical

Eli Lilly and Sigilon Therapeutics have announced a partnership that looks to break new ground in the management of type …

News

NICE rejects Dupixent for atopic dermatitis on cost grounds, Sanofi responds

April 4, 2018
Research and Development, Sales and Marketing Dupixent, NICE, Sanofi, atopic dermatitis, eczema, pharma

UK drug watchdog NCIE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of …

News
beam

Proton beam therapy finally arrives in UK

April 4, 2018
Medical Communications, Research and Development NHS, Proton beam therapy, biotech, drugs, pharma, pharmaceutical

28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has …

News
credit_ut_southwestern

Twin-drug combo effectively shrinks lung cancers by blocking their “escape route”

April 4, 2018
Research and Development Cancer, epidermal growth factor, lung cancer, pharma, tumour necrosis factor

A study conducted by researchers at UT Southwestern’s Simmons Cancer Center has revealed that a combination of two specific drug …

News
pfizer_chrome_plate

Pfizer running out of options for consumer business

April 4, 2018
Research and Development, Sales and Marketing P&G, Pfizer, Procter & Gamble, biotech, drugs, pharma, pharmaceutical

A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation …

News
shaking-hands-3091908_960_720

Ex-Kite execs form a CAR T rival

April 4, 2018
Research and Development, Sales and Marketing Allogene, Pfizer, biotech, drugs, pharma, pharmaceutical

After working to bring through Kite Pharma from the pre-clinical development stage to its final $12 billion acquisition by Gilead, …

News

Patient experience: Living with ovarian cancer

April 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma

Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …

Feature

One centre for cancer diagnoses trialled

April 3, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …

News
fda2outsideweb

Alkermes sent reeling as FDA refuses review of depression treatment

April 3, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma

Alkermes shares were knocked down to their lowest level since October 2016 after it was revealed that the FDA had …

News

Rumours Allergan is looking to offload $5bn women’s health unit

April 3, 2018
Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical

According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026